1. Home
  2. East Africa
  3. Burundi
  • News

Free anti-AIDS drug plan announced

Plans are underway in Burundi to make antiretroviral drugs freely available to people living with HIV/AIDS by December, the country's national AIDS body, Conseil National de lutte contre le Sida (CNLS) has said. Sixty percent of the CNLS budget already goes towards HIV/AIDS care, despite previous difficulties by the council in convincing donors to fund the purchase of anti-AIDS drugs. "Some of our donors have allowed us to buy antiretroviral drugs. Now, with the permission of the Global AIDS Fund, we will put all people living with HIV/AIDS under treatment," the technical director in the council, Dr Tharcisse Barihuta, told the UN news service, PlusNews. Barihuta said efforts had also been made to reduce the cost of anti-AIDS drugs from US $300 per month three years ago, to the current price of $30 per month. Research shows that globally Burundi is ranked 13th among countries most affected by HIV/AIDS, and second in central Africa.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join